Ascendis Pharma A/S 20-F for FY2025
Ascendis Pharma A/S (ASND)
20-F
2026-02-11
For: 2025-12-31
View Original
Added on
April 11, 2026
About this 20-F
Ascendis Pharma A/S filed this 20-F on February 11, 2026, covering the fiscal year ended December 31, 2025 (FY2025).
Headline figures
Fiscal year ended December 31, 2025, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- 720.13M EUR
- up 98.0% from 363.64M EUR a year earlier
- Net loss
- 228.03M EUR
- compared with a net loss of 378.08M EUR a year earlier
- Diluted EPS
- -3.76 EUR
- compared with -6.53 EUR a year earlier